Welcome to our dedicated page for AGGL news (Ticker: AGGL), a resource for investors and traders seeking the latest updates and insights on AGGL stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect AGGL's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of AGGL's position in the market.
On March 10, 2022, Agtech Global International, Inc. (OTC Pink: AGGL) announced the termination of its Memorandum of Understanding with Dr. Malcolm A. Leissring for the acquisition of NooMeds, LLC due to unexpected funding delays. As a result, Dr. Leissring will not serve as Chief Scientific Officer, and Agtech will cease involvement with the AD Foundation. Agtech continues to focus on the premium CBD consumer market through its acquisition of Galexxy Corporation and a joint venture with City Farm Industries, implementing a 'soil-to-sale' business strategy to enhance profit margins.
Agtech Global International, Inc. (OTC Pink: AGGL) has appointed Dr. Malcolm A. Leissring as Chief Science Officer effective January 1, 2022. This comes after Agtech's recent agreement to acquire NooMeds, LLC, which markets the dietary supplement A.L.Z. Defense™ aimed at preventing memory issues associated with Alzheimer's disease. Dr. Leissring, an award-winning neuroscientist with a strong background in Alzheimer's research, will direct the company's research and drug development efforts, focusing on psilocybin and CBD formulations.
Agtech Global International Inc. (OTC Pink: AGGL) is set to launch its innovative GENUS™ App, designed to transform the Hemp CBD market. This free app offers users discounted products and income-generating opportunities while providing health and wellness resources. The company's strategy includes rapid market penetration through its Virtual Retail Marketing System™ (VRMS) and the GENUS App, targeting millions of consumers. Agtech aims to enhance its product offerings with proprietary innovations and engage in substantial social media marketing.
Agtech Global International Inc. (OTC Pink: AGGL), a technology-driven CBD manufacturer, announced recent developments aimed at enhancing shareholder value and driving exponential revenue growth. The company is focusing on innovation through new product lines, including proprietary GENUS™ CBD products and a blockchain-enabled Virtual Retail Marketing System™. Notably, Agtech is pursuing a 10% equity stake in KRTL Biotech Inc., which specializes in psilocybin research. Plans for non-dilutive financing to support aggressive marketing initiatives were also revealed.
Agtech Global International Inc. (OTC Pink: AGGL) and KRTL Biotech Inc. have signed a Memorandum of Understanding to develop CBD and Psilocybin compounds to treat various debilitating conditions, including cancer pain and mental health issues. KRTL received approval from South Korea's Ministry of Food and Drug Safety to begin research on these compounds. AGGL plans to invest $2 million in KRTL, acquiring 10% equity shares with revenue-sharing rights. This collaboration aims to enhance market reach, focusing on the growing legal Psilocybin market in the U.S. and Asia.
Agtech Global International Inc. (OTC Pink: AGGL), soon to be renamed Galexxy Holdings Inc., has partnered with BlockCerts Blockchain to enhance its technological capabilities. This collaboration introduces a cloud-based, fully encrypted blockchain operating system that will support the upcoming launch of Galexxy's Genus™ products. The new system aims to streamline operations, improve supply chain control, and enhance customer transaction security. The innovative platform is expected to revolutionize how Galexxy engages with its customers in the CBD market, employing advanced digital solutions for secure payments and real-time tracking.
Agtech Global International Inc. (to be known as Galexxy Holdings Inc.) (OTC Pink: AGGL) has executed a Joint Venture Agreement with City Farm Industries Inc. for large-scale cultivation of Hemp CBD oils and isolate. The venture involves a 1,600-acre lease in California with $4.5 million in previous infrastructure investments. Galexxy plans staged capital investments of up to $10 million to enhance cultivation operations. This strategic move aims to secure the supply chain for quality CBD materials, maximizing product margins and advancing the company’s seed-to-sale model.
Galexxy Holdings Inc. (OTC: AGGL) has successfully trademarked its upcoming Genus™ CBD product brand, which will be marketed by its subsidiary, Galexxy Corporation. The innovative Virtual Retail Marketing System™ (VRMS) combines online shopping with physical retail experiences. Galexxy's strategy emphasizes a 'seed to sale' approach, linking health and wealth in the rapidly growing CBD market. The company aims to deploy VRMS across thousands of retail outlets, reaching millions of consumers.
Agtech Global International Inc. (OTC Pink: AGGL) has announced a Heads of Agreement to acquire NooMeds LLC, a dietary supplement company, from Dr. Malcolm A. Leissring. NooMeds is known for its A.L.Z. Defense supplement, aimed at memory health and tested in animal models for Alzheimer's disease. The acquisition, expected to finalize by August 31, will enhance the product with CBD and integrate it into Galexxy's Brain Health and Fitness segment. This move aligns with AGGL's strategy to enter the CBD consumer products market, addressing the growing demand for Alzheimer's solutions.
Agtech Global International Inc. (OTC Pink: AGGL) announced a name change to Galexxy Holdings, Inc., effective August 19, 2021, following board and shareholder approval. The change is subject to FINRA approval. Agtech is restructuring its operations to focus on premium CBD consumer products under a 'seed to sale' business strategy, emphasizing synergy between health and wealth.
FAQ
What is the market cap of AGGL (AGGL)?
